NVRNVR, Inc.Large cap · $17.38B · FY ending 2025-12-31
$6437.99-0.64% · 2026-07-13 · EOD
60/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality55
margins & F-ScoreValue78
P/E 14.7 · 29% of 12-mo rangeMomentum42
death · price below 200-daySmart Money64
buying · 2 funds · 1P/4S insidersMixed trendDeath crossBelow 200-day
vs S&P 500-21.5%
6-mo excess Trailing performance1M +2.1%
3M -4.6%
6M -12.8%
YTD -11.6%
1Y -16.3%
P/E vs its last 12 months (our price history): 12.7 low → 19.6 high
Current price sits at the 29th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Piotroski F4/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of ~21%. Annual figures from SEC XBRL.
Dividend & capital return
Shareholder yield10.5%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying1P / 4S insiders · 2 funds hold · 0 Congress buys
Recent insidersDeVito Michael J · DirectorBUY$73,695
Ross Susan Williamson · DirectorSELL$1.6M
Kelpy Matthew B. · VP, Chief Accounting OfficerSELL$4.0M
Ross Susan Williamson · DirectorSELL$1.6M
Fund holders (13F)Berkshire Hathaway (Warren Buffett)$73.2M0.0% of book
Broad Run Investment Management
Chealth · 66/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.